Holen Sie sich die Stockscreener-App
0.395
3.67%
0.014
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
Allurion launches AI weight loss support GLP-1 drug programme - Yahoo! Voices
Allurion launches compounded GLP-1 program as FDA aims to end access - Yahoo Finance
Allurion launches compounded GLP-1 program as FDA aims to ends access - Yahoo Finance
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program - The Bakersfield Californian
Allurion Technologies (NYSE:ALUR) Cut to Neutral at Chardan Capital - Defense World
Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83 - Yahoo Finance
Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper - Simply Wall St
Analysis of ARMISTICE CAPITAL, LLC's Recent Transaction in Allur - GuruFocus.com
Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Citadel Advisors LLC Acquires New Stake in Allurion Technologies Inc - GuruFocus.com
TD Cowen maintains buy rating for Allurion Technologies at $2.00 target - Investing.com UK
Earnings call: Allurion Technologies outlines strategy amid Q3 challenges - Investing.com
Earnings call: Allurion Technologies outlines strategy amid Q3 challenges By Investing.com - Investing.com Australia
Chardan Capital Downgrades Allurion Technologies (ALUR) - MSN
Allurion Technologies Inc (ALUR) Q3 2024 Earnings Call Highlights: Strategic Shifts and Revenue ... By GuruFocus - Investing.com Canada
Allurion Technologies Reports Q3 2024 Financial Performance - TipRanks
Allurion Technologies CFO Resigns, CEO Steps In - TipRanks
Allurion Technologies announces 50% reduction in workforce, operating expenses - Nasdaq
Allurion Technologies Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update - Marketscreener.com
Allurion Technologies (ALUR) Scheduled to Post Earnings on Wednesday - Defense World
Allurion boasts over 17% weight loss with swallowable balloon device - Yahoo Finance
Allurion reports significant weight loss in global patient study By Investing.com - Investing.com Canada
Allurion reports significant weight loss in global patient study - Investing.com India
Allurion Technologies presents data at Obesity Week - Nasdaq
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Business Wire
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com
Allurion sets date for first annual stockholders meeting By Investing.com - Investing.com Canada
Allurion sets date for first annual stockholders meeting - Investing.com
Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com
Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
RTW INVESTMENTS, LP Reduces Stake in Allurion Technologies Inc - GuruFocus.com
ALUR Stock Declines Despite Submitting PMA for Allurion Balloon - Yahoo Finance
Allurion Technologies (NYSE:ALUR) Shares Down 3.8% – Time to Sell? - Defense World
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion reports weight loss success with gastric balloon By Investing.com - Investing.com South Africa
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - Benzinga
Allurion’s swallowable balloon hits trial success amid weakening financials - Yahoo! Voices
Allurion reports weight loss success with gastric balloon - Investing.com India
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss - Marketscreener.com
Gevo Inc (GEVO-Q) QuotePress Release - The Globe and Mail
ALUR Stock Update: Allurion Technologies Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TD Cowen Initiates Coverage of Allurion Technologies (ALUR) with Buy Recommendation - Nasdaq
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail
S&P 500 Index (INX) QuotePress Release - The Globe and Mail
S&P 500 Industrials [Sector] (SRIN) QuotePress Release - The Globe and Mail
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):